FILE PHOTO: The U.S. flag is seen over the company logo for Johnson & Johnson to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. Photo by Brendan McDermid/Reuters.

J&J agrees to pay $230M to settle New York opioid claim

Nation

NEW YORK — The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.

The deal announced on Saturday requires Johnson & Johnson to make a series of payments over nine years that will cover the total. The drugmaker also agreed to end the manufacturing and distribution of opioids across New York and the rest of the nation, Attorney General Letitia James said in statement.

The company "helped fuel this fire, but today they're committing to leaving the opioid business — not only in New York, but across the entire country," James said.

Johnson & Johnson said in a statement on Saturday that the settlement "is not an admission of liability or wrongdoing by the company."

It added that its actions "relating to the marketing and promotion of important prescription pain medications were appropriate and responsible."

Support PBS News Hour

Your tax-deductible donation ensures our vital reporting continues to thrive.

J&J agrees to pay $230M to settle New York opioid claim first appeared on the PBS News website.

Additional Support Provided By: